Anxiety Medication and Pregnancy in Canada: Evidence-Based Guide

For pregnant Canadians with anxiety, the question is rarely just “is this medication safe?” — it's “is this medication safer than untreated anxiety?” The honest answer is that for many people, the balance favours treatment. Untreated moderate-to-severe anxiety in pregnancy is associated with preterm birth, low birth weight, postpartum depression, and impaired infant bonding. SSRIs and SNRIs carry small risks, but most are well-studied and the absolute risk increase is small. This guide walks through the evidence so you and your physician can make an informed choice.

If You're in Crisis

If you're having thoughts of self-harm, harming the baby, or suicide, call or text 9-8-8 (Canada Suicide Crisis Helpline), available 24/7. Pregnancy and the postpartum period have unique mental health risks — please reach out.

The Core Principle: Treatment vs Untreated Disease

Most prescribing decisions in pregnancy come down to a comparison: the risk of the medication vs the risk of leaving the disease untreated. For anxiety, untreated symptoms during pregnancy are not a benign default. The data show:

Increased risk of preterm birth in pregnancies with severe untreated anxiety
Lower birth weight independent of other factors
Higher rates of gestational hypertension and preeclampsia
Substantially increased risk of postpartum depression
Impaired infant bonding and altered early-life neurodevelopment

Against this backdrop, the small risks of well-chosen SSRIs are often the safer option. The right answer depends on severity, history, and individual factors — but it is rarely “just stop the medication.”

Which Medications Are Preferred

Preferred: Sertraline (Zoloft), escitalopram (Cipralex)

Most extensive safety data among SSRIs. Sertraline is the most-studied antidepressant in pregnancy. Both have low transfer into breast milk and are widely used in pregnancy and lactation.

Generally acceptable: Citalopram (Celexa), fluoxetine (Prozac)

Reasonable options if previously effective. Citalopram has slightly less data than sertraline/escitalopram. Fluoxetine has the longest half-life — less preferred to initiate in late pregnancy because of accumulation, but reasonable to continue.

Second-line / case-by-case: Venlafaxine XR (Effexor XR), duloxetine (Cymbalta)

Less long-term safety data than SSRIs. Reasonable to continue if previously the only effective treatment. Generally not first-line for new starts in pregnancy unless there is a specific indication.

Avoid if possible: Paroxetine (Paxil)

Small but significant increase in congenital cardiac malformations with first-trimester exposure. Sertraline and escitalopram are preferred alternatives. If a patient is stable on paroxetine and switching could destabilize them, the decision should be individualized.

Generally avoid: Benzodiazepines (lorazepam, clonazepam, alprazolam)

Late-pregnancy use linked to neonatal sedation, respiratory issues, and floppy infant syndrome. Long-term use also raises concerns about cleft palate (small absolute risk). Use only if benefit clearly outweighs risk and at lowest effective dose.

Specific Risks to Discuss With Your Doctor

Congenital malformations

Background rate of major malformations is ~3%. Most SSRIs do not raise this meaningfully. Paroxetine raises cardiac malformations by approximately 0.2-0.5 percentage points (still small absolute risk). Avoid if alternatives work.

Preterm birth

Small (1-2%) increase in preterm delivery has been observed with SSRI/SNRI exposure in late pregnancy. Untreated moderate-to-severe anxiety also increases preterm birth risk — net effect of treatment may be neutral or favourable.

Neonatal adaptation

~20-30% of late-exposure babies show transient jitteriness, mild respiratory issues, or feeding difficulty in the first 24-72 hours. Almost always self-resolves. Inform your delivery hospital so the baby is observed.

Persistent pulmonary hypertension

A rare condition (~1-2 per 1000 in untreated population). Some studies showed a modest increase with late-pregnancy SSRI exposure, others did not. Absolute risk remains very low. Most regulators no longer view this as a strong contraindication.

Postpartum hemorrhage

Slightly elevated risk with SSRI/SNRI exposure near delivery (relative risk ~1.3, small absolute increase). Worth flagging to your delivery team but rarely a reason to discontinue treatment.

Long-term neurodevelopment

Older studies suggested associations with autism or ADHD, but newer studies controlling for maternal mental illness find no consistent independent effect of SSRI/SNRI exposure on long-term neurodevelopment. Untreated maternal anxiety appears to be the larger risk factor.

Breastfeeding

SSRIs are compatible with breastfeeding for most patients. Drug transfer into breast milk is generally low and infant exposure is minimal.

Sertraline — first choice. Very low transfer; usually undetectable in infant serum.
Escitalopram — also widely considered safe. Low milk transfer.
Paroxetine — actually has favourable breastfeeding data despite pregnancy concerns. Reasonable for postpartum start.
Fluoxetine — long half-life means more accumulation in milk and infant. Less preferred to initiate during breastfeeding; reasonable to continue from pregnancy.
Venlafaxine, duloxetine — moderate transfer; generally compatible but less data than SSRIs.

If you are starting medication during breastfeeding, sertraline is usually the first choice. Healthy infants with normal weight gain rarely show any detectable effect.

If You're Already Pregnant on an Anxiety Medication

Don't stop abruptly. Sudden discontinuation of any SSRI/SNRI can cause withdrawal and a high rate of anxiety relapse.
Talk to your physician quickly, ideally within a few days. Not all changes are urgent, but the conversation should happen.
Continuing is often the right choice for moderate-to-severe anxiety on a well-tolerated SSRI like sertraline or escitalopram.
Switching from paroxetine to sertraline or escitalopram is reasonable if caught early in pregnancy and your symptoms are stable enough.
Tapering off is appropriate only for very mild symptoms with strong support systems and access to therapy — and even then under medical supervision.

Non-Medication First-Line Options

For mild-to-moderate anxiety, non-pharmacological options are worth trying first:

Cognitive behavioural therapy (CBT) — strong evidence in pregnancy; no fetal exposure. Look for a registered psychotherapist or psychologist with perinatal experience.
Interpersonal therapy — also evidence-based, particularly for anxiety with relational triggers.
Mindfulness-based stress reduction (MBSR) — 8-week structured programs; comparable efficacy to medication for some patients with mild-moderate anxiety.
Prenatal yoga and structured exercise — modest but consistent effect on anxiety symptoms; safe with obstetric clearance.
Sleep hygiene, social support, and reduction of identifiable stressors — adjuncts that compound the benefit of any other treatment.

A note on guilt.

Many pregnant patients feel guilty about taking medication or about needing it in the first place. Anxiety in pregnancy is common (10-20% of pregnant people meet criteria for an anxiety disorder), is not a parenting failure, and is highly treatable. Treating your anxiety is caring for your baby. Talk to a clinician who treats this every day — they will not judge you.

Frequently Asked Questions

Is it safe to take anxiety medication while pregnant?

For many patients with moderate to severe anxiety, the answer is yes — when carefully chosen. Untreated anxiety in pregnancy is itself associated with preterm birth, low birth weight, postpartum depression, and impaired bonding. The decision is not "medication or nothing" but a careful weighing of treatment risk against the risk of leaving anxiety untreated. SSRIs (especially sertraline and escitalopram) are the most commonly used and have the most reassuring safety data.

Which anxiety medications are preferred in pregnancy in Canada?

Sertraline (Zoloft) and escitalopram (Cipralex) are the most commonly preferred SSRIs for anxiety during pregnancy. Both have extensive safety data and are not associated with significant teratogenic risk above background. Paroxetine should be avoided due to a small increased risk of cardiac malformations. Among SNRIs, venlafaxine and duloxetine have less long-term safety data and are second-line in pregnancy unless there is a clear indication.

Why is paroxetine avoided in pregnancy?

Multiple cohort studies and a large meta-analysis have linked first-trimester paroxetine exposure to a small but significant increase in congenital cardiac malformations, particularly atrial and ventricular septal defects. The absolute risk increase is small (background cardiac defect rate is about 1%; paroxetine raises it by approximately 0.2-0.5 percentage points), but because alternatives like sertraline and escitalopram do not show this signal, paroxetine is generally avoided.

Is untreated anxiety a problem during pregnancy?

Yes — and this is a critical part of the conversation. Untreated moderate-to-severe anxiety in pregnancy is associated with preterm birth, low birth weight, gestational hypertension, increased rates of postpartum depression, and difficulty bonding with the infant. The risks of untreated anxiety must be weighed against the risks of medication. For moderate-to-severe anxiety, the balance often favours treatment.

Are there non-medication options I should try first?

Cognitive behavioural therapy (CBT) is highly effective for mild-to-moderate anxiety and has no fetal exposure risk. It is the recommended first-line treatment in pregnancy when symptoms are mild. For moderate-to-severe anxiety, CBT alone may be insufficient — combination treatment (CBT plus a low-dose SSRI) is often appropriate. Mindfulness-based stress reduction, prenatal yoga, and structured exercise also have evidence in pregnancy.

Can I take SSRIs while breastfeeding?

Yes. Sertraline is considered the SSRI of choice during breastfeeding due to very low transfer into breast milk and minimal infant exposure. Escitalopram is also widely considered safe. Fluoxetine has the longest half-life and accumulates more in breast milk, making it less preferred when starting during breastfeeding (though continuing it from pregnancy is reasonable). Most infants exposed via breast milk show no detectable adverse effects.

What is neonatal adaptation syndrome?

About 20-30% of newborns exposed to SSRIs or SNRIs in late pregnancy show transient symptoms in the first 24-72 hours: jitteriness, mild respiratory distress, feeding issues, or temperature instability. These are short-lived (typically resolve within a few days), do not require treatment in most cases, and have not been linked to long-term outcomes. Hospital staff should be informed of medication exposure so the baby can be observed.

Should I stop my anxiety medication when I find out I am pregnant?

Do not stop abruptly. Sudden discontinuation of SSRIs or SNRIs can trigger withdrawal symptoms and often causes anxiety relapse. The decision to continue, switch, taper, or change dose should be made with your physician, weighing your symptom history, severity, prior response, and the specific medication. Many patients do best by staying on a well-tolerated SSRI throughout pregnancy.

Is venlafaxine safe in pregnancy?

Venlafaxine is not contraindicated in pregnancy and is sometimes continued when it has been the only effective treatment for severe anxiety or panic disorder. A 2022 meta-analysis of cohort studies found SNRIs were not associated with a statistically significant increase in overall congenital malformations (RR 1.12, 95% CI 0.97-1.31). However, the safety data are less extensive than for SSRIs, so venlafaxine and duloxetine are generally second-line in pregnancy unless there is a clear indication.

Can I get pregnancy-aware anxiety care from a Canadian online doctor?

Yes. MediNote physicians are licensed Canadian family physicians who can review your medical history, weigh treatment options against the specific risks of pregnancy, prescribe pregnancy-preferred SSRIs when appropriate, and refer to obstetrics, perinatal psychiatry, or psychotherapy. Same-day appointments at $55 CAD. For complex cases, your physician may recommend consultation with a perinatal mental health specialist.

Anxiety Medication and Pregnancy: A Canadian Evidence-Based Guide